SCOPUS 정보 검색 플랫폼

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1532-1533

Melanoma in multiple sclerosis treated with natalizumab: Causal association or coincidence?

(2) Bergamaschi, Roberto a Montomoli, Cristina b

a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE (Italy)

b UNIVERSITY OF PAVIA (Italy)

Author keywords

Melanoma; Multiple sclerosis; Natalizumab

Indexed keywords

INTERFERON BETA SERINE; NATALIZUMAB;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; MELANOMA; MULTIPLE SCLEROSIS; NEVUS; NUCLEAR MAGNETIC RESONANCE IMAGING; SKIN SURGERY; SKIN ULCER;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MELANOMA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK FACTORS; SKIN NEOPLASMS;

EID: 72749090843 PISSN: 13524585 EISSN: None Source Type: Journal
DOI: 10.1177/1352458509347154 Document Type: Article

Times cited : (36)

References (10)

1
- 33644584352
- A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
- Polman CH, OConnor PW, Havrdova E., et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354: 899-910.
- (2006) N Engl J Med , vol.354 , pp. 899-910
- Polman, C.H.¹ Oconnor, P.W.² Havrdova, E.³

2
- 38949166754
- Melanoma complicating treatment with natalizumab for multiple sclerosis
- Mullen JT, Vartanian TK, Atkins MB Melanoma complicating treatment with natalizumab for multiple sclerosis. N Engl J Med 2008 ; 358: 647-648.
- (2008) N Engl J Med , vol.358 , pp. 647-648
- Mullen, J.T.¹ Vartanian, T.K.² Atkins, M.B.³

3
- 62849084585
- Melanoma following treatment with alemtuzumab for multiple sclerosis
- Pace AA, Zajicek JP Melanoma following treatment with alemtuzumab for multiple sclerosis. Eur J Neurol 2009 ; 16: e70-71.
- (2009) Eur J Neurol , vol.16 , pp. 70-71
- Pace, A.A.¹ Zajicek, J.P.²

4
- 46449083260
- More on melanoma with transdifferentiation
- Panzara MA, Bozic C., Sandrock AW More on melanoma with transdifferentiation. N Engl J Med 2008 ; 359: 99.
- (2008) N Engl J Med , vol.359 , pp. 99
- Panzara, M.A.¹ Bozic, C.² Sandrock, A.W.³

5
- 72749128154
- Biogen Idec and Elan. http://investor.biogenidec.com/phoenix.zhtml?c= 148682&p=irol-TPME (accessed June 2009 ).
- (2009) Biogen Idec and Elan

6
- 0035742712
- Epidemiology of cutaneous melanoma in Germany and worldwide
- Garbe C., Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001 ; 14: 280-290.
- (2001) Skin Pharmacol Appl Skin Physiol , vol.14 , pp. 280-290
- Garbe, C.¹ Blum, A.²

7
- 0013401756
- National Cancer Institute. Surveillance Epidemiology and End Results http://www.seer.cancer.gov,2005.statfacts/html/melan.html (accessed May 2009 ).
- (2009) Surveillance Epidemiology and End Results
- Cancer Institute, N.¹

8
- 4444378470
- A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic
- Edwards LJ, Constantinescu CS A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004 ; 10: 575.
- (2004) Mult Scler , vol.10 , pp. 575
- Edwards, L.J.¹ Constantinescu, C.S.²

9
- 65249086191
- Cancer risk among patients with multiple sclerosis and their parents
- Bahmanyar S., Montgomery SM, Hillert J., Ekbom A., Olsson T. Cancer risk among patients with multiple sclerosis and their parents. Neurology 2009 ; 72: 1170-1177.
- (2009) Neurology , vol.72 , pp. 1170-1177
- Bahmanyar, S.¹ Montgomery, S.M.² Hillert, J.³ Ekbom, A.⁴ Olsson, T.⁵

10
- 67649297820
- Quantitative risk-benefit analysis of natalizumab
- Thompson JP, Noyes K., Dorsey ER, Schwid SR, Holloway RG Quantitative risk-benefit analysis of natalizumab. Neurology 2008 ; 71: 357-364.
- (2008) Neurology , vol.71 , pp. 357-364
- Thompson, J.P.¹ Noyes, K.² Dorsey, E.R.³ Schwid, S.R.⁴ Holloway, R.G.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.